1021 10 (Alfuzosin Extended Release 10 mg)
Pill imprint 1021 10 has been identified as Alfuzosin hydrochloride extended release 10 mg.
Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 1021 10
More about alfuzosin
- Other brands: Uroxatral
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.